ABL1 and acute lymphoblastic leukemia: ABL-class fusions are a feature of approximately 3% of paediatric acute lymphoblastic leukaemia (ALL) cases [1, 2] with similar gene expression patterns to Philadelphia chromosome positive (Ph-pos) ALL and with generally poor responses to standard induction chemotherapy.